Separation Agreement and Release

Neoleukin Therapeutics, Inc.

Title: Separation Agreement and Release
Contract Category:Separation Agreement
Summary: This Separation Agreement and Release, dated August 5, 2019, is between Aquinox Pharmaceuticals (Canada) Inc. and David Main. The contract outlines the terms of Main's resignation and severance due to the company's merger, including compensation, benefits, and the return of company property.
Governing Law:British Columbia
Filer:Neoleukin Therapeutics, Inc. (NLTX)
Loading Spinner